Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,712.00
Bid: 1,711.80
Ask: 1,712.00
Change: 6.80 (0.40%)
Spread: 0.20 (0.012%)
Open: 1,701.60
High: 1,712.00
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: FCA, bank competition, Glaxo

Sun, 30th Mar 2014 16:53

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write to Chancellor George Osborne to complain about the FCA. Senior sources at four of Britain's biggest insurers told the paper Wheatley's position was untenable.Andrew Tyrie, Chairman of the Treasury Select Committee, has accused the Financial Conduct Authority of an "extraordinary blunder" in announcing market sensitive information about the insurance sector, the Sunday Telegraph reported. Insurer shares fell heavily on Friday after FCA Director of Supervision Clive Adamson told the Telegraph the watchdog planned an inquiry into pensions dating back to the 1970s. Tyrie said the FCA's pledge to bring in an external law firm to investigate the affair was not enough and that his committee would probably vet the inquiry head.The head of the Competition and Markets Authority (CMA) has said Labour leader Ed Miliband's plan for a swift breakup of Britain's banks is unworkable, the Sunday Telegraph reported. Alex Chisholm, Chief Executive of the new competition regulator, said an investigation would take at least 18 months and that any resulting disposals could take many years. Miliband said in January that a Labour government would introduce a threshold for personal current accounts and business banking and give the CMA six months to set the limit. Chisolm said the CMA, in shadow form, had been looking at small business banking for about six months.GlaxoSmithKline is planning a multimillion-pound investment in sub-Saharan Africa, the Sunday Telegraph reported. The pharmaceutical giant will announce plans to build up to five new factories on March 31st. It is looking at sites in Ghana, Ethiopia and Rwanda. Glaxo thinks Africa will be one of the fastest growing parts of the world over the next 50 years. Sub-Saharan Africa provides about £500m of Glaxo's £26.5bn annual sales.Land Securities has put on hold plans to build 200 luxury flats near Buckingham Palace until after next year's general election, the Sunday Times reported. The decision is the first sign that threats of a "mansion tax" are affecting developers' plans. The industry fears a 1% tax on homes worth more than £2m - a policy picked up by Labour that housebuilders are concerned the Conservatives will emulate.Royal Bank of Scotland is close to appointing Ewen Stevenson, one of the brains behind the 2008 banking bailout, as its new Finance Director, according to the Sunday Times. Stevenson, co-head of European investment banking at Credit Suisse, is said to have dreamt up the asset protection scheme insurance programme that stopped RBS shareholders being entirely wiped out during the financial crisis.A funding crisis has cast doubt on the future of Britain's second-biggest oil refinery, the Sunday Times said. The Stanlow plant is owned by Essar Energy, the Indian power and mining company whose founders are trying to buy it back after listing in London four years ago. Stanlow has to refinance a £330m loan from Barclays in July after using up £173m of its cash in the nine months to December. Essar said Stanlow was within its debt covenants and that the plant had the advantage of producing lots of diesel and jet fuel, of which the UK produces little.Real incomes in the UK are back to pre-financial crisis levels, the Sunday Times said. Figures in the small print of official figures released on March 28th showed real household disposable incomes were £507.7bn in the second half of last year - up 4% from the first half of 2008. Britain's population has risen in that time but by less than incomes. The figures suggest the squeeze on household budgets is easing fast.Card Factory is planning to join the line of retailers floating on the stock market with a share sale that could value the discount group at more than £700m, the Sunday Telegraph said. Its private equity owner, Charterhouse, is working on a flotation for this summer. Card Factory Chief Executive Richard Hayes told the paper he wanted to expand from 700 stores to as many as 1,100.A Chinese tycoon is in talks to buy House of Fraser for more than £450m, the Sunday Times reported. Yuan Yafei's Sanpower conglomerate has been in talks with House of Fraser for several months. The department store group's Chairman Don McCarthy has accepted the bid and has presented it to the company's other main shareholders for approval. The deal would end plans for House of Fraser to join the procession of retail initial public offerings.
More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.